Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
software
3
×
cancer
fda
investing
national top stories
new york blog main
new york top stories
takeda pharmaceutical
a2 biotherapeutics
aduro biotech
agency
agios pharmaceuticals
akili interactive labs
alicia hager
ally bridge group
alpha-1 antitrypsin
alzheimer's disease
amag pharmaceuticals
amgen
arca biopharma
arch venture partners
arrowhead pharmaceuticals
axovant gene therapies
bacteriophage
big data analytics
biogen
biontech
biotech ipos
blackrock
boston
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
What
bio
growing
ipo
medicines
alliance
analysis
biotech
bring
bristol
buy
calls
changing
color
company
company’s
course
crispr
days
develop
development
discover
diseases
drug
employing
experimental
genetic
goldfinch
handiwork
helped
hours
internal
kidney
kudos
landscape
later
lead
leaves
million
myers’s
new
Language
unset
3
×
Current search:
software
×
unset
×
biotech
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
